Browsing by Author "Custovic, A."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
    (2020) Papadopoulos, Nikolaos ; Mathioudakis, Alexander ; Custovic, A. ; Deschildre, Antoine ; Phipatanakul, Wanda ; Wong, Gary ; Xepapadaki, Paraskevi ; Abou Taam, Rola ; Agache, Ioana ; Castro-Rodriguez, Jose ; Chen, Zhimin ; Cros, Pierrick ; Dubus, Jean Christophe ; El-Sayed, Zeinab ; El-Owaidy, Rasha ; Feleszko, Wojciech ; Fierro, Vincenzo ; Fiocchi, Alessandro ; Garcia-Marcos, Luis ; Goh, Anne Eng Neo ; Hossny, Elham ; Huerta Villalobos, Yunuen ; Jartti, Tuomas ; Le Roux, Pascal; Levina, Julia ; López-García, Aída ; Mazon, Angel ; Morais-Almeida, Mário; Murray, Clare; Nagaraju, Karthik ; Nagaraju, Major ; Navarrete Rodriguez, Elsy Maureen ; Namazova-Baranova, Leyla ; Nieto, Antonio ; Pozo Beltrán, Cesar Fireth ; Ratchataswan, Thanaporn ; Rivero-Yeverino, Daniele ; Rodriguez-Zagal, Erendira ; Schweitzer, Cyril; Tulkki, Marleena ; Wasilczuk, Katarzyna ; Xu, Dan
  • Thumbnail Image
    Item
    Infantile and preschool asthma
    (2012) Castro-Rodriguez, J.A.; Rodriguez-Martinez, C.E.; Custovic, A.
    In infants and preschool children the symptoms suggestive of asthma (e.g. wheeze) may be a clinical expression of a number of diseases with different aetiologies. If this is true, then it is unlikely that these different diseases would respond to the same treatment. Consequently, implementation of a management strategy which is effective for each individual patient is challenging, and controversies remain with respect to which patients should be given anti-asthma treatment, and when the treatment should be started and for how long. Whilst acknowledging these uncertainties, practicing physicians may use the Asthma Predictive Index (API) as a guide in clinical practice to identify young children with recurrent wheezing who are at risk of the subsequent development of persistent asthma, and who may benefit from preventative anti-asthma medication. We acknowledge that a number of questions on the most appropriate management strategy remain unanswered, including which type of medication is the best for individual patients (e.g. short-acting beta-agonist versus inhaled corticosteroid (ICS) versus leukotriene receptor antagonist (LTRA)), dose (high versus low) and schedule (regular versus as needed).